SHA:603229 Market Cap

SHA:603229 has a market cap or net worth of 8.26 billion as of April 21, 2026. Its market cap has increased by 16.87% in one year.

Market Cap

8.26B

Enterprise Value

7.50B

Revenue

751.12M

Ranking

n/a

PE Ratio

45.03

Stock Price

9.87

Market Cap Chart

Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 8.26B, an increase of 358.79%. That is a compound annual growth rate of 18.55%.

Market Cap History

Date	Market Cap	% Change
Apr 20, 2026	8.26B	0.50%
Dec 31, 2025	8.22B	-0.94%
Dec 31, 2024	8.29B	5.87%
Dec 29, 2023	7.83B	-18.09%
Dec 30, 2022	9.56B	-8.49%
Dec 31, 2021	10.45B	19.25%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
May 9, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
China Resources Boya Bio-pharmaceutical Group Co.,Ltd	9.50B
Sino Biological,Inc.	9.15B
Shanghai Medicilon	9.14B
Youcare Pharmaceutical Group	8.86B
Daan Gene	8.29B
Jiangsu Aidea Pharmaceutical Group	8.15B
Acrobiosystems	8.05B
Chengdu Kanghua Biological Products	7.77B

Market Cap Rankings